CTNI-48. A PHASE 0 ‘TRIGGER’ TRIAL OF CDK4/6 PLUS ERK1/2 INHIBITORS IN RECURRENT GLIOBLASTOMA

Authors: Nader Sanai, Yu-Wei Chang, Tigran Margaryan, Anita DeSantis, Mackenna Elliott, Chelsea Pennington-Krygier, Garry Hook, Wonsuk Yoo, An-Chi Tien, Artak Tovmasyan, Shwetal Mehta

Published: 2021-11-18

DOI: 10.1093/neuonc/noab196.273

Source: Full article

CTNI-48. A PHASE 0 ‘TRIGGER’ TRIAL OF CDK4/6 PLUS ERK1/2 INHIBITORS IN RECURRENT GLIOBLASTOMA

Abstract